4/22
02:11 pm
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Low
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
4/16
08:40 am
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
Low
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
4/16
08:40 am
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
Low
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
4/16
08:20 am
krys
Rating for KRYS
Low
Report
Rating for KRYS
2/27
12:23 pm
krys
Rating for KRYS
Medium
Report
Rating for KRYS
2/27
12:23 pm
krys
Rating for KRYS
Medium
Report
Rating for KRYS
2/27
12:14 pm
krys
Rating for KRYS
Medium
Report
Rating for KRYS
2/27
12:14 pm
krys
Rating for KRYS
Medium
Report
Rating for KRYS
2/27
09:30 am
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "outperform" rating re-affirmed by analysts at William Blair.
2/27
09:30 am
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "outperform" rating re-affirmed by analysts at William Blair.